AdvisorShares Pure US Cannabis ETF (MSOS)

NYSEArca

4.90
-0.06 (-1.11%)
Updated Sep 1, 6:15 PM ET
AI Rating
Strong Buy
Overall Score
83
Trend
93
Momentum
94
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

AdvisorShares Pure US Cannabis ETF is trading at $4.90, down 1.11% on the session. The 50 day average sits at $4.56 and the 200 day at $4.38, which puts the stock in a uptrend. RSI is at 62.8, which reads as strong, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $4.44 with resistance near $5.15, so that band frames the current range. Average daily movement is roughly $0.22, or about 4.5% of the share price, which is what any stop placement has to allow for. The overall health score of 83 out of 100 combines a trend score of 93, momentum of 94 and a risk score of 52.

Technical indicators

RSI (14)
62.8
strong
MACD
0.125
bullish crossover
SMA 20
4.61
SMA 50
4.56
SMA 200
4.38
uptrend
ATR (14)
0.22
avg daily range
Support
4.44
Resistance
5.15
Volume vs 20d
2.13x
volume spike
Volatility
52.3%
annualised
1 month
+18.53%
3 months
+1.42%

About AdvisorShares Pure US Cannabis ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.